Professor Graham Darby
(Chairman) |
Antiviral Drug Discovery |
Independent consultant. Formerly Head of Antiviral Research at GSK. |
| Dr. David Knowles |
Drug Discovery |
CSO/R&D Director of Piramed, UK. Formerly CSO at Ribotargets and Head of Anti-microbial Research at SKB. |
| Dr. Alan Hudson |
Medicinal Chemistry |
Independent consultant. Formerly Head of Cancer Research at Wellcome Research Laboratories. |
| Professor Robert Glen |
Chemoinformatics |
Director of the Unilever Centre of Molecular Informatics, University of Cambridge. Formerly Tripos and Wellcome. |
| Dr. Stanley Lemon |
HCV Research (Molecular pathogenesis of viral hepatitis) |
Dean of Medicine, The University of Texas. |
| Professor Richard Whitley |
Clinical Virology |
Professor of Pediatrics and the Director of the Center for Biodefense and Emerging Infections at the University of Alabama at Birmingham, USA. Also leads the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group whose role is to perform clinical trials of antiviral therapies. |
| Professor Graham Foster |
Clinical Virology |
Professor of Hepatology, Barts and The London Medical School, Queen Mary University, London. |
| Professor Jane McKeating |
The mechanism(s) of Hepatitis C virus-cell entry, infection and interaction |
Division of Immunity and Infection, Institute of Biomedical Research Medical School, University of Birmingham. |
